Trial intelligence / Profile preview

LT4 + LT3 versus LT4 + placebo in post-surgical hypothyroidism

2017-001261-25Phase 4Completed

Sponsor
Policlinico Federico II
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in post-surgical hypothyroidism comparing Levothyroxine + Liotir with Levothyroxine + placebo (2 arms). Primary endpoint: Efficacy on thyroid function, metabolic, and cardiovascular parameters. Started Jun 2021; status: completed.

02

Drugs

liothyroninelevothyroxine sodium
03

Conditions

post-surgical hypothyroidism

Beyond the preview

Go deeper on 2017-001261-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-001261-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call